Champlain Investment Partners, LLC Procept Bio Robotics Corp Transaction History
Champlain Investment Partners, LLC
- $15.8 Billion
- Q3 2024
A detailed history of Champlain Investment Partners, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 650,293 shares of PRCT stock, worth $58.1 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
650,293
Previous 1,365,279
52.37%
Holding current value
$58.1 Million
Previous $83.4 Million
37.54%
% of portfolio
0.33%
Previous 0.53%
Shares
5 transactions
Others Institutions Holding PRCT
# of Institutions
267Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$433 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$312 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$137 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$111 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$105 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.99B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...